-
Ras C-terminal processing enzymes--new drug targets?
Cell. 1991 Apr 5;65(1):1-4
PMID: 2013090
-
Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells.
J Virol. 1981 May;38(2):632-48
PMID: 6264134
-
Early events in Epstein-Barr virus infection of human B lymphocytes.
Virology. 1991 Apr;181(2):595-608
PMID: 1849678
-
Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
Nature. 1991 Feb 14;349(6310):612-4
PMID: 1705663
-
Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
J Virol. 1991 Apr;65(4):1701-9
PMID: 1848303
-
Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
J Virol. 1991 May;65(5):2545-54
PMID: 1850028
-
New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma.
Nature. 1982 Jan 14;295(5845):160-3
PMID: 6276755
-
Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.
J Virol. 1982 Jul;43(1):262-72
PMID: 6180174
-
Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript.
J Virol. 1983 Oct;48(1):135-48
PMID: 6310141
-
DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
Nature. 1984 Jul 19-25;310(5974):207-11
PMID: 6087149
-
Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection.
Proc Natl Acad Sci U S A. 1982 Sep;79(18):5698-702
PMID: 6291060
-
Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.
J Virol. 1982 Dec;44(3):834-44
PMID: 6294333
-
Assembly of the mitochondrial membrane system. Structure and nucleotide sequence of the gene coding for subunit 1 of yeast cytochrme oxidase.
J Biol Chem. 1980 Dec 25;255(24):11927-41
PMID: 6254986
-
Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
Virology. 1979 Jun;95(2):351-8
PMID: 223286
-
Complexity of EBV homologous DNA in continous lymphoblastoid cell lines.
Virology. 1976 Oct 1;74(1):227-31
PMID: 185788
-
DNA sequencing with chain-terminating inhibitors.
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
PMID: 271968
-
Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
Proc Natl Acad Sci U S A. 1972 Feb;69(2):383-7
PMID: 4333982
-
Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
J Virol. 1976 Jun;18(3):1071-80
PMID: 178913
-
Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Biomedicine. 1975 Jul;22(4):276-84
PMID: 179629
-
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
Nature. 1990 Nov 22;348(6299):334-6
PMID: 2250705
-
An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.
J Virol. 1991 Jul;65(7):3681-92
PMID: 1710288
-
Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1546-50
PMID: 1847527
-
DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences.
EMBO J. 1989 Dec 20;8(13):4273-9
PMID: 2686984
-
Structure-independent DNA amplification by PCR using 7-deaza-2'-deoxyguanosine.
Nucleic Acids Res. 1988 Oct 25;16(20):9869
PMID: 3186456
-
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
EMBO J. 1987 Sep;6(9):2743-51
PMID: 2824192
-
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
Proc Natl Acad Sci U S A. 1987 Nov;84(22):8060-4
PMID: 2825176
-
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62
PMID: 2556717
-
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6
PMID: 3033649
-
Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
Nature. 1989 Aug 3;340(6232):393-7
PMID: 2547164
-
Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.
Proc Natl Acad Sci U S A. 1989 Jun;86(12):4589-93
PMID: 2543982
-
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.
Cell. 1989 Apr 7;57(1):79-88
PMID: 2649247
-
Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
Cell. 1986 Oct 10;47(1):19-28
PMID: 2875799
-
The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.
J Virol. 1988 Jul;62(7):2337-46
PMID: 2836616
-
A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.
J Virol. 1988 Jul;62(7):2274-84
PMID: 2836611
-
Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes.
Proc Natl Acad Sci U S A. 1988 Jun;85(11):3678-82
PMID: 2836854
-
Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.
Oncogene. 1988 May;2(5):461-7
PMID: 2836780
-
Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
Virology. 1987 Sep;160(1):151-61
PMID: 2820125
-
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.
J Virol. 1987 Dec;61(12):3672-9
PMID: 2824806
-
Oncogenic potential of bcl-2 demonstrated by gene transfer.
Nature. 1988 Nov 17;336(6196):259-61
PMID: 2848196
-
Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
Cell. 1988 Nov 4;55(3):427-33
PMID: 2846181
-
Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
J Virol. 1988 Nov;62(11):4173-84
PMID: 2845129
-
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
Cell. 1985 Dec;43(3 Pt 2):831-40
PMID: 3000618
-
Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome.
J Virol. 1987 Sep;61(9):2902-9
PMID: 3039177
-
The BamHI F region of the B95-8 Epstein-Barr virus genome.
Virology. 1985 Nov;147(1):99-109
PMID: 2998075
-
Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H.
J Virol. 1985 Aug;55(2):286-97
PMID: 2991556
-
Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.
Proc Natl Acad Sci U S A. 1989 Mar;86(6):1958-62
PMID: 2538824
-
Elevated recombination rates in transcriptionally active DNA.
Cell. 1989 Feb 24;56(4):619-30
PMID: 2645056
-
Mechanism of antigen-driven selection in germinal centres.
Nature. 1989 Dec 21-28;342(6252):929-31
PMID: 2594086
-
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
Nature. 1988 Sep 29;335(6189):440-2
PMID: 3262202
-
Polyoma virus DNA replication requires an enhancer.
Nature. 1984 Nov 15-21;312(5991):242-6
PMID: 6095089
-
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.
Cell. 1986 Jan 31;44(2):283-92
PMID: 3943125
-
Protein kinase activity associated with a cell cycle regulated, membrane-bound Epstein-Barr virus induced early antigen.
Intervirology. 1990;31(1):1-13
PMID: 2159954
-
The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
J Virol. 1990 Jun;64(6):2530-6
PMID: 2159528
-
Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
J Virol. 1990 Jul;64(7):3407-16
PMID: 2352328
-
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
J Virol. 1990 May;64(5):2309-18
PMID: 2157887
-
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
J Immunol. 1990 May 1;144(9):3602-10
PMID: 2184193
-
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
J Virol. 1990 Mar;64(3):1002-13
PMID: 2154588
-
Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes.
J Virol. 1990 Apr;64(4):1667-74
PMID: 2157049
-
A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.
J Virol. 1990 May;64(5):2319-26
PMID: 2157888
-
Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6343-7
PMID: 1648738